A. Lindblad (Gothenburg, Sweden), M. Muhlebach (Chapel Hill, Nc, United States of America)
The importance of expiratory flow rate measuring in the differential diagnosis of chronic bronchial obstruction in children S. Sciuca, O. Turcu, R. Selevestru, E. Chioroglo (Chisinau, Republic Of Moldova)
| |
Poor outcomes in cystic fibrosis – a challenging experience in eastern Europe L. Dracea, L. Pop, L. Tamas (Brasov, Timisoara, Romania)
| |
Transition from paediatric to adult care: perspective of an adult CF-centre M. Hofer, C. Benden, G. M. Tini, R. Spinas-Haeller, A. Moeller, P. Eng, A. Boehler (Zurich, Aarau, Switzerland)
| |
Neural respiratory drive and disease severity in cystic fibrosis C. Reilly, K. Ward, C. Jolley, A. Lunt, J. Steier, C. Elston, G. F. Rafferty, J. Moxham (London, United Kingdom)
| |
Depression and anxiety in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis I. Gaspar-Garcia, C. Olveira-Fuster, F. Espildora-Hernandez, G. Olveira-Fuster, A. Dorado-Galindo, A. Padilla-Galo, J. J. Cebrian-Gallardo, J. L. De la Cruz-Rios (Marbella, Malaga, Spain)
| |
Sputum biomarkers of inflammatory in children with cystic fibrosis T. Bulgakova, E. Surkova, L. Jelenina, E. Boitsova, E. Dotcenko, T. Gembitskaia (Saint-Petersburg, Russian Federation)
| |
Circulating inflammatory cytokines in adult cystic fibrosis patients J. Gozdzik, A. Nowicka, S. Cofta, T. Piorunek (Poznan, Poland)
| |
Aerobic training in children with cystic fibrosis A. C. Oliveira, J. C. Oliveira, T. Alma de Jesus, V. F. Souza, L. V. Oliveira, L. Sampaio (Sao Paulo, Brazil)
| |
Audit of management of pseudomonas aeruginosa infection in children with cystic fibrosis A. Chingale, C. Upton, A. Betteridge (Norwich, United Kingdom)
| |
Comparison of clinical features in patients with cystic fibrosis according to the age at diagnosis R. Athanazio, S. Rached, S. Azevedo, R. Carvalho-Pinto, A. Cuckier, R. Stelmach (São Paulo, Brazil)
| |
Oxygen kinetics during submaximal cardiopulmonary exercise testing (CPET) in adult patients with cystic fibrosis is related to maximal exercise breathing pattern E. Armeniakou, G. Perpati, M. Avdikou, C. Pappas, E. Stefanatou, T. Soulele, V. Nanou, P. Roditis, E. Pouliou, S. Nanas (Athens, Greece)
| |
Non invasive ventilation (NIV) assists chest physiotherapy for treatment of patients with cystic fibrosis A. Petrone, M. Quartieri, A. Tolisano, C. Tirone, F. Tirone (Lungro, Rome, Italy)
| |
Effect of n-butyldeoxynojirimycin on chloride efflux from CF airway epithelial cells I. Oliynyk, G. M. Roomans (Örebro, Sweden)
| |
28 years of newborn screening in the U.K.: false negatives S. A. McAuley, J. Calvin, F. MacLean, R. Iles (Cambridge, United Kingdom)
| |
Genotype based evaluation of eradication treatment for p. aeruginosa infections in CF patients P. Schelstraete, P. Deschaght, L. Van Simaey, S. Van Daele, F. Haerynck, M. Vaneechoutte, F. De Baets (Ghent, Belgium)
| |
The role of cardio pulmonary exercise testing (CPET) in patients with cystic fibrosis (CF) M. Damin, A. Borruso, L. Menin, B. M. Assael, U. Pradal (Padova, Verona, Italy)
| |
Effect of long term treatment with azithromycin on clinical status and lung function parameters in cystic fibrosis patients colonised by pseudomonas aeruginosa A. Vracaric, P. Minic (Uzice, Belgrade, Republic Of Serbia)
| |